https://www.selleckchem.com/pr....oducts/limertinib.ht
The registration number of this review study protocol is CRD42020210879. In this review, we included eight published papers comprising 2,186 participants. The estimated pooled proportion of knowledge of the participants was 43.0% (95%CI23.0-64. while the pooled estimates of attitudes and practices were 38.0% (95%CI 1.0-77. and 41.0% (95%CI 4.0-77., respectively. The proportion of the outcome variables were extremely heterogeneous across the studies with I2 98%). The pooled estimates of knowledge, attitude and practice were
Like
Comment
Share
